Image credit Weight loss is an incredible journey; if you’ve been through it, you know how frustrating and overwhelmin ...

NBC 7 dives deep into the explosive popularity of the medications and explores both the life-changing benefits and the ...

NBC 7 dives deep into the explosive popularity of the medications and explores both the life-changing benefits and the ...

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

GLP-1R agonist use is associated with a decrease in IOP, although this correlation is not statistically significant.

Real-world studies on GLP-1s like Ozempic show lower weight loss than clinical trials, with high discontinuation rates due to ...

Glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, have dominated headlines for their ...

Whether a drug that selectively targets fat mass, with modest weight loss, translates into CV benefits awaits further study.

Tirzepatide, a dual GIP and GLP-1 receptor agonist, has gained widespread recognition for its effectiveness in promoting substantial weight loss by enhancing metabolic functions and controlling ...

This is particularly important as many existing weight-loss medications, such as GLP-1 receptor agonists, often lead to muscle wasting as a side effect. Deniel Mero, Co-Founder of Elevai Biosciences, ...

After 19 weeks on daily oral HU6 treatment, people shed on average 2.9 kg (~6.3 lb) or 2.7% of their starting body weight relative to placebo, both significant changes supporting some efficacy of the ...

In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and ...